AUS
NZ
UK
CA
USA
IND
Healthcare
Biofrontera stock (BFRI) rallies 115%, fired up by upbeat rating
November 24, 2021 10:50 AM PST| By Rupam RoyHighlights Analysts raised the 12-month stock price target to US$20. The BFRI jumped 115% in intraday trading after the positive comments. The Massachusetts-based company specializes in dermatology drugs and medical cosmetics, mainly for skin .....
Ocuphire Pharma (OCUP) stock jumped 34% - know why?
November 24, 2021 08:39 AM PST| By Rupam RoyHighlights Ocuphire Pharma announced the number of participants for the MIRA-3 Phase 3 trial. CEO Mina Sooch said the company will submit a new drug application (NDA) for Nyxol eye drops after the trial results. The company reported a net loss.....
Pasithea Therapeutics (KTTA) stock soars 229% - Know why?
November 23, 2021 12:29 PM PST| By Rupam RoyHighlights Pasithea Therapeutics' (KTTA) wholly-owned subsidiary Pasithea Clinics got approval for its anti-depressant esketamine nasal spray, SPRAVATO. The KTTA stock jumped over 229% in intraday trading on Tuesday. Currently, only three clin.....
Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?
November 23, 2021 11:27 AM PST| By Versha JainHighlights Qualigen Therapeutics, Inc. (NASDAQ: QLGN) soared 32% in intraday trading on Tuesday. Its third-quarter revenue rose to US$US$1.16 million compared to a net loss of US$8.11 million a year ago. The company develops novel therapeutic .....
Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO
November 23, 2021 08:07 AM PST| By Rupam RoyHighlights Aadi Bioscience announced FDA approval for its injectable drug FYARRO. FYARRO is the only FDA-approved therapy for advanced malignant PEComa in adults. The AADI stock rose over 62% YTD. Shares of Aadi Bioscience, Inc. (NASDAQ: .....
Why did MultiPlan Corporation (MPLN) stock jump 33% today?
November 22, 2021 03:28 PM PST| By Versha JainHighlights MultiPlan Corporation (NASDAQ: MPLN) stock closed at 33% higher on Monday. The company expects to obtain the resale registration statement on Dec 10, 2021. It announced to participate in the virtual BofA Leverage Finance Conference .....
Why is iSpecimen Inc. (ISPC) stock making headlines today?
November 22, 2021 10:26 AM PST| By Rupam RoyHighlights iSpecimen Inc. (ISPC) said that it secured a contract to support new research on covid. The stocks were up more than 130% on Monday morning. The company's revenue was up 21% YoY in Q3, FY21. The stocks of the online marketplace.....
Why ObsEva SA (OBSV) stock jumped on Monday?
November 22, 2021 09:08 AM PST| By Rupam RoyHighlights FDA has agreed to review the new drug application (NDA) for Linzagolix. It has set Sep 13, 2022, as a target date for the NDA review under the Prescription Drug User Fee Act (PDUFA). ObsEva announced the appointment of Stephanie Bro.....
Longeveron (LGVN) shares soared 138%, do you know why?
November 18, 2021 10:00 AM PST| By Rupam RoyHighlights FDA has granted rare-pediatric-disease (RPD) designation to Longeveron’s cellular therapy Lomecel-B. Longeveron is currently evaluating Lomecel-B in a Phase 2 trial. All the infants enrolled in its Lomecel-B Phase 1 trial were.....
Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more
November 18, 2021 09:55 AM PST| By Versha JainHighlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investment from Pfizer Inc. Cardiff plans to use the proceeds for its ongoing clinical research in KRAS-mu.....
Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket
November 18, 2021 08:18 AM PST| By Versha JainHighlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical development of its first investigational therapeutic in 2022. The transaction, which would be de.....
Progenity (PROG) stock continues rally, up 21%: Here’s why
November 17, 2021 08:32 AM PST| By Raza NaqviHighlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged over 220% in Q3, FY21 PROG stocks were up more than 20% in pre-market trading today The sto.....
Why did Altamira Therapeutics (CYTO) stock skyrocket today?
November 12, 2021 12:29 PM PST| By Ipsita SarkarHighlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval for Bentrio on Oct 14. Altamira’s operating loss was about US$7.01 million for the six months.....
Eyeing for JNJ stock? Know why J&J is splitting into 2 companies
November 12, 2021 09:53 AM PST| By Ipsita SarkarHealthcare company Johnson & Johnson (NYSE: JNJ) announced on Friday to split the business into two companies in the next two years, triggering a flurry of speculation in the market. The stock jumped more than 2% in the premarket trading after.....
AstraZeneca (AZN) revenue skyrockets; is the stock worth exploring?
November 12, 2021 09:10 AM PST| By Versha JainHighlights AstraZeneca PLC (NASDAQ: AZN) revenue increased 50% YoY to US$9.877 billion in the third quarter ended September 30, 2021. However, it reported a loss of US$1.98 billion or US$(1.10) per share diluted in the quarter. AstraZenec.....
Is RenovoRx (RNXT) stock worth exploring? Know more.
November 10, 2021 10:49 AM PST| By Ipsita SarkarHighlights RenovoRx, Inc. (NASDAQ: RNXT) stock jumped over 66% in premarket on Wednesday. The company had made a presentation on its therapeutic platform a day earlier. RenovoRx, Inc. went public in August through a Nasdaq listing. Biopha.....
CVS (CVS), Humana (HUM) revise guidance after strong Q3 results
November 03, 2021 10:24 AM PDT| By Versha JainHighlights CVS Health Corporation (NYSE: CVS) revenue rose 10% YoY to US$73.8 in Q3. Humana Inc. (NYSE: HUM) revenue rose 3% to US$20.7 billion in the third quarter. Both the companies have revised their full-year 2021 revenue guidance. .....
Pfizer (PFE) raises guidance after Q3 revenue jumps 134%
November 02, 2021 10:26 AM PDT| By Versha JainHighlights Pfizer, Inc. (NYSE: PFE) revenue increased by 134% YoY to US$24.1 billion in Q3. The company raised guidance for fiscal 2021 after robust quarterly performance. On Oct 29, it received FDA approval for its covid booster dose, Comirna.....
Why did ABVC stock jump more than 200% today?
November 01, 2021 09:50 AM PDT| By Versha JainABVC Biopharma, Inc. (NASDAQ: ABVC) jumped more than 219% on Monday after receiving approval from Taiwan Central Institutional Review Board to start Phase 2 trial of its attention-deficit ADHD drug. The stock traded at US$8.11, up 219.29% fro.....
AbbVie (ABBV) raises full-year guidance after Q3 revenue boost
October 29, 2021 10:09 AM PDT| By Ipsita SarkarHighlights AbbVie Inc. (NYSE: ABBV) posted third-quarter revenue of US$14.342 billion, up 11.2% YoY. It raised the GAAP diluted EPS guidance to around US$6.29 to US$6.33 per share. ABBV also announced a dividend increase of 8.5% or US$1.41 pe.....
